Kurs kaydını izlemek için tıklayınız.

• 4. Modül Programı
• Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with reviously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study
• Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
• Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: long term follow-up from a Phase 1b study
• Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
• ASH 2021: Kabul Edilen AML Venetoklaks Kullanımı İlişkili Bildiriler
• Genetic Basis of Acute Lymphoblastic Leukemia
• Genetic Testing in the Diagnosis and Biology of Acute Leukemia
• Next-Generation Sequencing in Acute Lymphoblastic Leukemia
• Measurable Residual Disease Response and Prognosis in Treatment-Na¨ıve Acute Myeloid Leukemia With Venetoclax and Azacitidine
• Secondary AML Emerging After Therapy with Hypomethylating Agents: Outcomes, Prognostic Factors, and Treatment Options
• Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study
• Clinical presentation of childhood leukaemia: a systematic review and meta-analysis
• Epidemiology and Etiology of Leukemia and Lymphoma
• Acute lymphoid leukemia etiopathogenesis
• Familial aggregation of early-onset haematological malignancies
• Infection, immune responses and the aetiology of childhood leukaemia
• Hereditary Predisposition to Hematopoietic Neoplasms: When Bloodline Matters for Blood Cancers
• Acute lymphoblastic leukaemia
• Acute Myeloid Leukemia in Children
• The Evolution of Allogeneic Stem Cell Transplant for Children and Adolescents With Acute Myeloid Leukemia